Crystal Horizon Investments

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 1, 2017	Rani Therapeutics	$39.0M Series D	—	Byers Capital, Founders' Co-op, Seven Seven Six, Susa Ventures, Y Combinator, Justin Mateen, AstraZeneca, Bossanova Investimentos, Buttonwood, Cathay Innovation, Google Ventures, Novartis, Pacific Venture Opportunity Fund, Pinemount Investments

Total Raised

N/A

Valuation

N/A